Pandemic Forces F.D.A. to Sharply Curtail Drug Company Inspections
The steep decline in oversight has stalled a number of new drug applications. The agency says it is trying to protect its employees but critics say inspectors should be considered essential workers and do their jobs.
The F.D.A. conducted more than 1,671 inspections of foreign and domestic drug manufacturing facilities in 2019. Last year, that number dropped by more than half, to 742. Credit.Ariana Lindquist/Bloomberg
March 9, 2021
The Covid-19 pandemic has forced the Food and Drug Administration to postpone hundreds of drug company inspections, creating an enormous backlog that is delaying new drug approvals and leading the industry to warn of impending shortages of existing medicines.
POLITICO
Get Playbook PM
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Presented by Facebook
Rep. Alexandria Ocasio-Cortez (D-N.Y.) has been among the most vocal opponents of this rule aimed at protecting House Democrats from challengers on the left, i.e. challengers just like her. | Seth Wenig/AP Photo
DCCC Chair SEAN PATRICK MALONEY (D-N.Y.) this morning nixed the committee’s “blacklist” policy banning work with contractors who help candidates primary incumbents. But let s be clear about who really brought this thing down: Rep.